Zobrazeno 1 - 10
of 250
pro vyhledávání: '"lanadelumab"'
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background Hereditary angioedema (HAE) is a rare and potentially life-threatening disease that manifests clinically as recurrent episodes of swelling affecting multiple anatomical locations. Long-term prophylaxis (LTP) aims to control the di
Externí odkaz:
https://doaj.org/article/07047515d77d454f9ca53edccb0015a2
Autor:
Antonio Gidaro, Leyla La Cava, Mattia Donadoni, Valentina Popescu Janu, Chiara Cogliati, Antonio Luca Brucato, Andrea Zanichelli, Mauro Cancian, Emanuele Bizzi
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionCardiovascular pathologies represent the first cause of death in uremic patients and are among the leading causes of mortality in patients with hereditary angioedema due to C1-inhibitor deficiency (HAE-C1INH). Before 2020, the most common
Externí odkaz:
https://doaj.org/article/e4294dd02fb542d38f1ada3f2ad89949
Autor:
Kanarek HJ, Mutschelknaus DAS
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 17, Pp 123-132 (2024)
Henry J Kanarek,* Drew Austin Saville Mutschelknaus* Kanarek Allergy, Asthma & Immunology, Leawood, KS, USA*These authors contributed equally to this workCorrespondence: Henry J Kanarek, Tel +1 (913) 451-8555, Fax +1 (913) 327-8553, Email
Externí odkaz:
https://doaj.org/article/40a563a3e9da4d9aa339765b9d7b7aa3
Autor:
Thomas Buttgereit, Carolina Vera Ayala, Seda Aykanat, Karsten Weller, Annika Gutsche, Marcus Maurer, Markus Magerl
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionLanadelumab is a first-line long-term prophylaxis (LTP) in hereditary angioedema (HAE). Real-life data on its long-term efficacy and safety are limited. It is unknown whether patients using lanadelumab need short-term prophylaxis (STP).Ob
Externí odkaz:
https://doaj.org/article/7536b60b93bf481ea32a454fc35cf1e6
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/0f84a52f5f454695a2268ec5ca4094d6
Autor:
Jane C.Y. Wong, MBBS, FHKCP, Valerie Chiang, MBBS, Dorothy L.Y. Lam, MSc, Elaine Lee, MSc, Ki Lam, MBBS, FRCPA, Elaine Y.L. Au, FRCPA, FHKCPath, Philip H. Li, MD, FRCP
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 2, Iss 4, Pp 100166- (2023)
Background: With no approved long-term prophylaxis (LTP) for the prevention of hereditary angioedema (HAE) attacks in Hong Kong, patients rely on compassionate use programs and drug trials. Moreover, studies regarding the use and efficacy of LTP in A
Externí odkaz:
https://doaj.org/article/6b9b9958f7c3421b9fafa812eb34a3d6
Autor:
Carolina García Rosas, J Jesus López Tiro, Angélica Contreras Contreras, Martha Ruiz Peñaloza, Zayra Estefanía Ortíz Morteón
Publikováno v:
Revista Alergia México, Vol 70, Iss 3 (2023)
Antecedentes: El angioedema hereditario tipo 1 (AEH1) es un trastorno autosómico dominante, caracterizado por la carencia cuantitativa y cualitativa del C1 inhibidor, producción excedida de bradicinina y causar angioedema recurrente en diversos gra
Externí odkaz:
https://doaj.org/article/a27b6f894370435eb6475c3c6fe38e00
Publikováno v:
Allergology International, Vol 72, Iss 1, Pp 54-62 (2023)
Monoclonal antibodies (mAbs) have been shown to be effective and generally safe across a continually expanding list of therapeutic areas. We describe the advantages and limitations of mAbs as a therapeutic option compared with small molecules. Specif
Externí odkaz:
https://doaj.org/article/9523315bb0944351a744ccfb8bffd0b6
Publikováno v:
Drug, Healthcare and Patient Safety, Vol Volume 14, Pp 195-210 (2022)
Elena Petkova, Vanya Yordanova, Maria Staevska, Anna Valerieva Department of Allergology, Medical University of Sofia, University Hospital “Alexandrovska”, Sofia, BulgariaCorrespondence: Anna Valerieva, Email anna.valerieva@gmail.comAbstract: Her
Externí odkaz:
https://doaj.org/article/64921f1470d84977945631a2a4d4d8f2
Autor:
Timothy J. Craig, Rafael H. Zaragoza-Urdaz, H. Henry Li, Ming Yu, Hong Ren, Salomé Juethner, John Anderson, the HELP and HELP OLE Study Investigators
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 18, Iss 1, Pp 1-10 (2022)
Abstract Background The COVID-19 pandemic has highlighted disparities in healthcare, particularly in the United States, even though disparities have existed since the organization of the modern healthcare system. Recruitment of patients from racial a
Externí odkaz:
https://doaj.org/article/20b92af9a7e44f66bc6ab35c91efca41